When will the FDA approve Compass Pathways' COMP360 Psilocybin?

Prediction market on kalshi. If the FDA approves COMP360 Psilocybin for Treatment-Resistant Depression for marketing before Jul 1, 2027, then the market resolves to Yes.

24h Volume: $5. Liquidity: $2,885.54. Resolves: 7/8/2027.